Bilimsel çalışmalar

Prof. Dr. Mehmet Mustafa Can

204 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. A49. Ozturk S, Durmus G, Kalyoncuoglu M, Sari M, Ozbek O, Can M. Unroofed Coronary Sinus Atrial Septal Defect Misdiagnosed as Ostium Primum Defect. Korean Circ J.

    Kaynak: medicana.com.tr profil sayfası

  2. 2018 ;48(1):89-90. doi: 10.4070/kcj.2017.0131

    Kaynak: medicana.com.tr profil sayfası

  3. A50. Sahin M, Öztürk S, Mert TI, Durmuş G, Can MM. Coronary artery bypass surgery in Syrian refugees. Outcomes in a Turkish tertiary center. Saudi Med J. 2018;39(8):781-786. doi: 10.15537/smj.2018.8.22498.

    Kaynak: medicana.com.tr profil sayfası

  4. A51. Durmuş G, Belen E, Can MM. Increased neutrophil to lymphocyte ratio predicts myocardial injury in patients undergoing non-cardiac surgery. Heart Lung. 2018. doi: 10.1016/j.hrtlng.2018.01.005.

    Kaynak: medicana.com.tr profil sayfası

  5. A52. Durmuş G, Belen E, Bayyigit A, Kalyoncuoğlu M, Can MM. The Relationship between Inter-Arm Blood Pressure Difference and Coronary Artery Disease Severity

    Kaynak: medicana.com.tr profil sayfası

  6. Calculated by the SYNTAX Score. Int J Hypertens. 2018 ;2018:9370417. doi: 10.1155/2018/9370417.

    Kaynak: medicana.com.tr profil sayfası

  7. A53. Durmuş G, Belen E, Bayyiğit A, Can MM. Comparison of Complication and Success Rates of ProGlide Closure Device in Patients Undergoing TAVI and Endovascular Aneurysm Repair. Biomed Res Int. 2018:2687862. doi: 10.1155/2018/2687862.

    Kaynak: medicana.com.tr profil sayfası

  8. A54. Toptas M, Yalcin M, Akkoc İ, Demir E, Metin C, Savas Y, Kalyoncuoglu M, Can MM. The Relation between Sarcopenia and Mortality in Patients at Intensive Care Unit. Biomed Res Int. 2018 ;2018:5263208. doi: 10.1155/2018/5263208.

    Kaynak: medicana.com.tr profil sayfası

  9. A55. Toptas M, Sengul Samanci N, Akkoc İ, Yucetas E, Cebeci E, Sen O, Can MM, Ozturk S. Factors Affecting the Length of Stay in the Intensive Care Unit: Our Clinical Experience. Biomed Res Int. 2018;2018:9438046. doi: 10.1155/2018/9438046.

    Kaynak: medicana.com.tr profil sayfası

  10. A56. Toptas M, Akkoc İ, Savas Y, Uzman S, Toptas Y, Can MM. Novel hematologic inflammatory parameters to predict acute mesenteric ischemia. Blood Coagul Fibrinolysis. 2016 ;27(2):127-30. doi: 10.1097/MBC.0000000000000372.

    Kaynak: medicana.com.tr profil sayfası

  11. A57 Baydar O, Kilic A, Okcuoglu J, Apaydin Z, Can MM. The Triglyceride-Glucose Index, a Predictor of Insulin Resistance, Is Associated With Subclinical Atherosclerosis. Angiology. 2021 Nov;72(10):994-1000. doi: 10.1177/00033197211007719. Epub 2021 Apr 23. PMID: 33887969.

    Kaynak: medicana.com.tr profil sayfası

  12. A58. Biter Hİ, Kalyoncuoğlu M, Tosu AR, Çakal S, Apaydın Z, Gümüşdağ A, Çınar T, Eyüpkoca F, Belen E, Can MM. Prognostic value of the TyG index for in-hospital mortality in nondiabetic COVID-19 patients with myocardial injury. Rev Assoc Med Bras (1992). 2022 Sep;68(9):1297-1302. doi: 10.1590/1806-9282.20220410. PMID: 36228261; PMCID: PMC9575008.

    Kaynak: medicana.com.tr profil sayfası

  13. A59. Durmuş G, Belen E, Can MM. Increased neutrophil to lymphocyte ratio predicts myocardial injury in patients undergoing non-cardiac surgery. Heart Lung. 2018 May-Jun;47(3):243-247. doi: 10.1016/j.hrtlng.2018.01.005. Epub 2018 Feb 27. PMID: 29500104.

    Kaynak: medicana.com.tr profil sayfası

  14. A60. Cakal S, Cakal B, Güven Z, Tosu AR, Kalyoncuoglu M, Biter HI, Apaydın Z, Karaca IO, Belen E, Can MM. Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina. J Clin Med. 2021 Jun 2;10(11):2463. doi: 10.3390/jcm10112463. PMID: 34199404; PMCID: PMC8199609.

    Kaynak: medicana.com.tr profil sayfası

  15. A61. Kalyoncuoğlu M, Katkat F, Biter HI, Cakal S, Tosu AR, Can MM. Predicting One-Year Deaths and Major Adverse Vascular Events with the Controlling Nutritional Status Score in Elderly Patients with Non-ST-Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention. J Clin Med. 2021 May 22;10(11):2247. doi: 10.3390/jcm10112247. PMID: 34067233; PMCID: PMC8196821.

    Kaynak: medicana.com.tr profil sayfası

  16. A62. Kilic A, Baydar O, Elcioglu BC, Camkiran V, Apaydin Z, Can MM, Elcik D. Understanding Vascular Age: Are Clinical scoring systems useful for Early Vascular Aging Syndrome Prediction ? High Blood Press Cardiovasc Prev. 2020 Dec;27(6):569-577. doi: 10.1007/s40292-020-00417-7. Epub 2020 Oct 26. PMID: 33104966.

    Kaynak: medicana.com.tr profil sayfası

  17. A63. Sogut O, Can MM, Guven R, Kaplan O, Ergenc H, Umit TB, Demir O, Kaya M, Akdemir T, Cakmak S. Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational study. Am J Emerg Med. 2021 Feb;40:41-46. doi: 10.1016/j.ajem.2020.12.014. Epub 2020 Dec 11. PMID: 33348222; PMCID: PMC7836768.

    Kaynak: medicana.com.tr profil sayfası

  18. A64. Tosu AR, Kalyoncuoglu M, Biter Hİ, Cakal S, Selcuk M, Çinar T, Belen E, Can MM. Prognostic Value of Systemic Immune-Inflammation Index for Major Adverse Cardiac Events and Mortality in Severe Aortic Stenosis Patients after TAVI. Medicina (Kaunas). 2021 Jun 8;57(6):588. doi: 10.3390/medicina57060588. PMID: 34201104; PMCID: PMC8228319.

    Kaynak: medicana.com.tr profil sayfası

  19. A65. Söğüt Ö, Akdemir T, Can MM. Prognostic value of the C-reactive protein to albumin ratio in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Turk J Med Sci. 2021 Jun 28;51(3):1281-1288. doi: 10.3906/sag-2003-188. PMID: 33453709; PMCID: PMC8283510.

    Kaynak: medicana.com.tr profil sayfası

  20. B1.Kaymaz C, Keleş N, Tanboga IH, Can MM, Tokgöz H.C, Koca F, Ozkan A, Sonmez K, Saglam M, Ozdemır N.The effects of pre, peri or postprocedural infusion of tirofiban on angiographic measures, ST segment resolution, and in-hospital clinical outcome after primay PCI Eur Heart J (2011) 32 (suppl 1): 313-631 DOI: http://dx.doi.org/10.1093/eurheartj/ehr323

    Kaynak: medicana.com.tr profil sayfası

  21. B2. Biteker M, Biteker F, Ilhan E, Dayan A, Can M.M., Duman D. C-Reactive Protein (CRP) can predict perioperative major cardiovascular events in patients undergoing noncardiac, nonvascular surgery PCI Eur Heart J (2011) 32 (suppl 1): 313-631 DOI: http://dx.doi.org/10.1093/eurheartj/ehr323B3.

    Kaynak: medicana.com.tr profil sayfası

  22. B3.Biteker M, Dayan A, Tekkeşin A, Can M.M., Ilhan E.Incidence, risk factors, and outcomes of perioperative Acute Kidney Injury in noncardiac and nonvascular surgery Eur Heart J (2012) 33 (suppl 1): 655-939 DOI: http://dx.doi.org/10.1093/eurheartj/ehs283

    Kaynak: medicana.com.tr profil sayfası

  23. B4. Can MM, Tanboga I.H, Tokgoz H.C., Saglam M, Ozdemir N, Kaymaz C. The prognostic value of PET/CT uptake of bone marrow in patients with idiopathic pulmonary arterial hypertension PCI Eur Heart J (2011) 32 (suppl 1): 313-631 DOI: http://dx.doi.org/10.1093/eurheartj/ehr323

    Kaynak: medicana.com.tr profil sayfası

  24. B5. Biteker M, Dayan A,Can M.M., Ilhan E, Tekkesin T Preoperative statin use and postoperative atrial fibrillation after major noncardiac, nonvascular surgery Eur Heart J (2012) 33 (suppl 1): 655-939 DOI: http://dx.doi.org/10.1093/eurheartj/ehs283

    Kaynak: medicana.com.tr profil sayfası

  25. B6. Biteker M, Ilhan E ,Can M.M., Tekkesin T, Dayan A . The predictive value of preoperative B-type natriuretic peptide for major adverse cardiac/noncardiac events in patients undergoing noncardiac, nonvascular surgery Eur Heart J (2012) 33 (suppl 1): 19-338 DOI: http://dx.doi.org/10.1093/eurheartj/ehs281

    Kaynak: medicana.com.tr profil sayfası

  26. B7.Biteker M, Misirli C.H., Dayan A, Tekkeşin A, Ozden T,Can M.M, Ilhan E. Left atrial volume indexis an independent predictor of mortality after a firts -ever acute ischemic stroke Eur Heart J (2012) 33 (suppl 1): 19-338 DOI: http://dx.doi.org/10.1093/eurheartj/ehs281

    Kaynak: medicana.com.tr profil sayfası

  27. B8. Biteker M, Can M.M, Biteker F, Ilhan E, Dayan A, Duman D. An unforgotten predictor of perioperative outcome in patients undergoing noncardiac surgery:pulmonary hypertension Eur Heart J (2011) 32 (suppl 1): 1-312 DOI: http://dx.doi.org/10.1093/eurheartj/ehr322

    Kaynak: medicana.com.tr profil sayfası

  28. B9.Biteker M, Dayan A, Can M.M, Ilhan E, Duman D. Impact of perioperative glucose levels on perioperative cardiovascular outcomes in patients unergoing intermediate-risk mojor noncardiacsurgeryEurHeartJ (2011) 32 (suppl1): 1312 DOI: http://dx.doi.org/10.1093/eurheartj/ehr322

    Kaynak: medicana.com.tr profil sayfası

  29. B10. I.H Tanboga, Tokgoz H.C., Can M.M, Bezgin T, Turkyilmaz E, Akgun T, Sonmez K, Saglam M, Ozdemir N, Kaymaz C. The polymorphisms of CYP2C19, CYP3A5 and CYP2C9 enzymes in relation to platelet response to clopidogrel as assessed by multiplate analyser and long-term clinical outcome Eur Heart J (2013) 30 (suppl 1): 1-300

    Kaynak: medicana.com.tr profil sayfası

  30. B11. Tokgoz H.C., I.H Tanboga, , Can M.M, Bezgin T, Akgun T, Turkyilmaz E, Sonmez K, Saglam M, Ozdemir N, Kaymaz C. Does platelet response to clopidogrel and/or aspirin as assessed by multiplate analyser predict short and long term outcome following coronary stenting Eur Heart J (2013) 30 (suppl 1): 1-300

    Kaynak: medicana.com.tr profil sayfası

  31. B12. Tokgoz H.C., I.H Tanboga, , Ozkan A, Can M.M, Koca F, Bezgin T, Keles N, Ozveren O, Ozdemir N, Kaymaz C. A novel Doppler parameter, apical systolic flow in prediction of mitral regurgitation severity: Reappraisal of regurgitaion dynamics Eur Heart J (2013) 30 (suppl 1): 1-300

    Kaynak: medicana.com.tr profil sayfası

  32. B13. Tokgoz H.C., Ozkan A, I.H Tanboga, , Koca F, Can M.M, Keles N, Bezgin T, Sonmez K, Ozdemir N, Kaymaz C. Color M- mode regurgitant flow propagation velocity in quantitaion of mitral regurgitation:A high negative predictive value of jet eccentricity and dp/dt Eur Heart J (2013) 30 (suppl 1): 1-300

    Kaynak: medicana.com.tr profil sayfası

  33. B14. Can MM, Tanboga I.H, Tokgoz H.C., Keles N, Koca F, Ozkan A, Turkyilmaz E, Ozveren O, Sonmez K,Saglam M, Kaymaz C. Does heart rate variability predict te prognose in patinets with pulmonary arterial hypertension Eur Heart J (2013) 30 (suppl 1): 1-300

    Kaynak: medicana.com.tr profil sayfası

  34. B15. Can MM, Tanboga I.H, Turkyilmaz E, Akgun T, Koca F, Tokgoz H.C., Ozkan A, Bezgin T, Ozveren O, Kaymaz C. Characterization of platelet activity in paitients with pulmonary arterial hypertension. ESC 2013

    Kaynak: medicana.com.tr profil sayfası

  35. B16. Koca F, Can MM, Tanboga I.H, Ozkan A, Tokgoz H.C., Keles N, Bezgin T , Akgun T, Turkyilmaz E, Kaymaz C. Is neutrophil gelatinase-associated lipocalin a marker of renotubular dysfunction in pulmonary arterial hypertension characterised by low arteriovenous perfusion gradients Eur Heart J (2013) 30 (suppl 1): 1-300

    Kaynak: medicana.com.tr profil sayfası

  36. B17. Can MM, Tanboga I.H, Ozkan A, Koca F, Keles N, Tokgoz H.C, Yaymaci B, Sonmez K, Saglam M, Kaymaz C. In vitro assesment of platelet activity in patients with pulmonary arterial hypertension Eur Heart J (2012) 30 (suppl 1): 1-300

    Kaynak: medicana.com.tr profil sayfası

  37. B18. Can MM, Tanboga I.H, Turkyilmaz E, Akgun T, Koca F, Tokgoz H.C., Ozkan A, Bezgin T , Ozveren O, Kaymaz C. Increased platelet reactivity and thrombogenesis in pulmonary arterial hypertension subgroups Eur Heart J (2009) 30 (suppl 1): 587-843 DOI: http://dx.doi.org/10.1093/eurheartj/ehp415

    Kaynak: medicana.com.tr profil sayfası

  38. B19. Tanboga I.H, Can MM, Tokgoz H.C, Akgun T, Turkyilmaz E, , Keles N, Ozkan A, Ozveren O, Kaymaz C. Role of brain natriuretic peptide levels in predicting the acute clinical worsening episodes and response to ilioprost infusion in patients with pulmonary arterial hypertension.EurHeartJ (2009) 30 (suppl1): 587843 DOI: http://dx.doi.org/10.1093/eurheartj/ehp415

    Kaynak: medicana.com.tr profil sayfası

  39. B20. Can MM, Tanboga I.H, Tokgoz H.C., , Koca F, Ozkan A, Turkyilmaz E, Ozveren O, Sonmez K, Kaymaz C. The effects of long-term specific therapy on clinical outcome, echocardiographic ans sympatho-vagal balance as assessed by heart rate variability in pulmonaryarterialhypertension.EurHeartJ (2009) 30 (suppl1): 587843 DOI: http://dx.doi.org/10.1093/eurheartj/ehp415

    Kaynak: medicana.com.tr profil sayfası

  40. B21. Can MM, Tanboga I.H, Tokgoz H.C., Turkyilmaz E, Akgun T, Koca F, Ozkan A, Saglam M, Ozveren O, Kaymaz C. Does sympathovagal imbalance predict clinical outcome in patienys with PAH? Eur Heart J (2009) 30 (suppl 1): 1-300 DOI: http://dx.doi.org/10.1093/eurheartj/ehp413.

    Kaynak: medicana.com.tr profil sayfası

  41. B22. Karabay C, Can MM, Tanboga I.H, Akgun T, Turkyilmaz E, Ozkan A, Koca F, Keles N, Bezgin T, Saglam M, Yaymaci B, Sonmez K, Ozdemir N, Kaymaz C. Verify-Now Assay had discordant results as compared to Impedance Aggregometry in the evaluation of antiplatelet treatment in patients with stenting. 77th Congress of the European Atherosclerosis Society, İSTANBUL, TÜRKIYE, 26-29 Temmuz 2008, vol.9

    Kaynak: medicana.com.tr profil sayfası

  42. B23. Tanboga I.H, Tokgoz H.C, Can MM, Turkyilmaz E, Akgun T , Karabay C.Y, Bezgin T, Keles N, Koca F, Ozkan A, Sonmez K, Sağlam M, Yaymaci B, Ozdemir N, Kaymaz C. Does serum Lipoprotein (a) corelates to different riskfactors, coronary artery disease and angiographic data? 77th Congress of the European Atherosclerosis Society, İSTANBUL, TÜRKIYE, 26-29 Temmuz 2008, vol.9

    Kaynak: medicana.com.tr profil sayfası

  43. B24. Turkyimaz E, Tanboga I.H, Tokgoz H.C, Can MM, Akgun T, Bezgin T, Karabay C.Y, Keles N, Ozkan A, Koca F, Saglam M, Yaymaci B, Sonmez K, Ozdemir N, Kaymaz C. Serum Lipoprotein (a) and homocysteine levels related to five risk scores for coronary artery disease. 77th Congress of the European Atherosclerosis Society, İSTANBUL, TÜRKIYE, 26-29 Temmuz 2008, vol.9

    Kaynak: medicana.com.tr profil sayfası

  44. B25. Koca F, Keles N, Tokgoz H.C, Ozkan A, Tanboga I.H, Karabay C.Y, Can MM, Bezgin T, Akgun T, Turkyimaz E, Saglam M, Yaymaci B, Sonmez K, Bitigen A, Mutlu B, Duran N, Ozdemir N, Kaymaz C. Does clopidogrel provide an additıve early benefit in patients under the tirofiban treatment? 77th Congress of the European Atherosclerosis Society, İSTANBUL, TÜRKIYE, 26-29 Temmuz 2008, vol.9

    Kaynak: medicana.com.tr profil sayfası

  45. B26. Can MM, Tanboga I.H, Akgun T, Turkyimaz E , Tokgoz H.C, Keles N, Koca F, Ozkan A, Karabay C.Y, Bezgin T, Dogan C, Omaygenc O, Yaymaci B, Sonmez K, Saglam M, Ozdemir N, Kaymaz C. Does types of bare metal or drug eluting stents, clinical and biochemical markers of atherothrombosis attenuate the effect of antiplatelets. 77th Congress of the European Atherosclerosis Society, İSTANBUL, TÜRKIYE, 26-29 Temmuz 2008, vol.9

    Kaynak: medicana.com.tr profil sayfası

  46. B27. Can MM, Tanboga I.H, Tokgoz H.C., Karabay C.Y, Akgun T, Turkyilmaz E, Keles N, Ozkan A, Koca F, Bezgin T, Yaymaci B, Kaymaz C. The characteristics of acute clinical worsening in pulmonary hypertension, and substantial benefit from ilioprost infusion added on specific treatment. European Journal of Clinical Investigation 2008;38

    Kaynak: medicana.com.tr profil sayfası

  47. B28. Keles N, Tokgoz H.C., Koca F, Tanboga I.H, Karabay C.Y, Can MM, Bezgin T, Turkyilmaz E, Akgun T, Sonmez K, Yaymaci B, Bitigen A, Duran N.E,Mutlu B, Ozdemir N, Kaymaz C. Effects of tirofiban on angiographic measures, st resolution, and clinical outcome following the primary coronary intervention in patients with STEMI. 77th Congress of the European Atherosclerosis Society, İSTANBUL, TÜRKIYE, 26-29 Temmuz 2008, vol.9

    Kaynak: medicana.com.tr profil sayfası

  48. B29. Can MM, Tanboga I.H, Turkyilmaz E, Akgun T, Tokgoz H.C., Karabay C.Y, Bezgin T, Keles N, Ozkan A, Koca F, Yaymaci B, Kaymaz C. Does platelet activity have to be maesured before the treatment toı reflect the antiplatelets effect properly European Journal of Clinical Investigation 2008;38

    Kaynak: medicana.com.tr profil sayfası

  49. B30.Can MM, , Tokgoz H.C., , Turkyilmaz E, Tanboga IH, Akgun T, Ozkan A, Keles N, Koca F, Sonmez K, Kaymaz C. The characteristics of acute clinical worsening in pulmonary hypertension, and substantial benefit from ilioprost infusion added on specific treatment. Eur Heart J (2013) 30 (suppl 1): 1-300

    Kaynak: medicana.com.tr profil sayfası

  50. B31. Can MM, Canpolat N, Tanboga IH, Saglam M, Yaymaci B, Kaymaz C. Does enhanced F18 flurodeoxyglucose accumulation in right ventricular myocardium predict the severity of the disease and correlate with contractile function of the right ventricule? . European Journal of Clinical Investigation 2008;38

    Kaynak: medicana.com.tr profil sayfası